Do active site conformations of small ligands correspond to low free-energy solution structures?

We compare the low free energy structures of ten small, polar ligands in solution to their conformations in their respective receptor active sites. The solution conformations are generated by a systematic search and the free energies of representative structures are computed with a continuum solvation model. Based on the values of torsion angles, we find little similarity between low energy solution structures of small ligands and their active site conformations. However, in nine out of ten cases, the positions of 'anchor points' (key atoms responsible for tight binding) in the lowest energy solution structures are very similar to the positions of these atoms in the active site conformations. A metric that more closely captures the essentials of binding supports the basic premise underlying pharmacophore mapping, namely that active site conformations of small flexible ligands correspond to their low energy structures in solution. This work supports the efforts of building pharmacophore models based on the information present in solution structures of small isolated ligands.

[1]  G. Klebe The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands. , 1994, Journal of molecular biology.

[2]  Richard A. Friesner,et al.  Solvation Free Energies of Peptides: Comparison of Approximate Continuum Solvation Models with Accurate Solution of the Poisson−Boltzmann Equation , 1997 .

[3]  D W Zaharevitz,et al.  The discovery of novel, structurally diverse protein kinase C agonists through computer 3D-database pharmacophore search. Molecular modeling studies. , 1994, Journal of medicinal chemistry.

[4]  H M Holden,et al.  The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis. , 1989, The Journal of biological chemistry.

[5]  Dorica Mayer,et al.  A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies , 1987, J. Comput. Aided Mol. Des..

[6]  A. Leslie Refined crystal structure of type III chloramphenicol acetyltransferase at 1.75 A resolution. , 1990, Journal of molecular biology.

[7]  M. Noble,et al.  The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes , 1991, Proteins.

[8]  D E Tronrud,et al.  Crystallographic structural analysis of phosphoramidates as inhibitors and transition-state analogs of thermolysin. , 1989, European journal of biochemistry.

[9]  J. Warwicker,et al.  Calculation of the electric potential in the active site cleft due to alpha-helix dipoles. , 1982, Journal of molecular biology.

[10]  W L Jorgensen,et al.  Rusting of the lock and key model for protein-ligand binding. , 1991, Science.

[11]  M. Karplus,et al.  Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.

[12]  T Honma,et al.  Novel angiotensin II receptor antagonists. Design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f]oxepin derivatives. Searching for bioisosteres of biphenylyltetrazole using a three-dimensional search technique. , 1995, Journal of medicinal chemistry.

[13]  Robert Huber,et al.  On the disordered activation domain in trypsinogen: chemical labelling and low‐temperature crystallography , 1982 .

[14]  Garland R. Marshall,et al.  Sampling conformational hyperspace: Techniques for improving completeness , 1995, J. Comput. Aided Mol. Des..

[15]  J. Skehel,et al.  Refinement of the influenza virus hemagglutinin by simulated annealing. , 1991, Journal of molecular biology.

[16]  David E. Clark,et al.  Active-site-directed 3D database searching: Pharmacophore extraction and validation of hits , 1996, J. Comput. Aided Mol. Des..

[17]  R. Sheridan,et al.  The ensemble approach to distance geometry: application to the nicotinic pharmacophore. , 1986, Journal of medicinal chemistry.

[18]  Anil K. Jain,et al.  Algorithms for Clustering Data , 1988 .

[19]  Y. Martin,et al.  3D database searching in drug design. , 1992, Journal of medicinal chemistry.

[20]  Garland R. Marshall,et al.  Constrained search of conformational hyperspace , 1989, J. Comput. Aided Mol. Des..

[21]  Peter G. Schultz,et al.  The Immunological Evolution of Catalysis , 1996, Science.

[22]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[23]  Gerhard Klebe,et al.  What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .

[24]  J. Wendoloski,et al.  Structural origins of high-affinity biotin binding to streptavidin. , 1989, Science.

[25]  M C Nicklaus,et al.  Conformational changes of small molecules binding to proteins. , 1995, Bioorganic & medicinal chemistry.